Dermatophagoides farinae
- Generic Name
- Dermatophagoides farinae
- Brand Names
- Acarizax, Odactra
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- PR9U2YPF3Q
- Background
Dermatophagoides farinae extracts are sterile solutions used for intradermal testing or subcutaneous immunotherapy. This combination is approved for as a year-round, once-a-day tablet that's dissolved under the tongue as a treatment for dust mite allergies.
- Indication
Dermatophagoides farinae is indicated as immunotherapy for house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides farinae or Dermatophagoides pteronyssinus house dust mites, or skin testing to licensed house dust mite allergen extracts. It is approved for use in patients 12 through 65 years of age.
- Associated Conditions
- House Dust Mite Allergy
- Associated Therapies
- -
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
- Conditions
- Rhinitis, AllergicHouse Dust Mite RhinitisMite Allergy
- Interventions
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- RAPHAS
- Target Recruit Count
- 54
- Registration Number
- NCT05525650
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Registration Number
- NCT03513458
Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Registration Number
- NCT03513471
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.